BioCentury | May 30, 2018
Distillery Therapeutics

Cancer

...expression. Next steps could include testing ESRRG agonists in animal models of gastric cancer. TARGET/MARKER/PATHWAY: Estrogen-related receptor...
...CONTACT: Yun-Yong Park, same affiliation as above email: yypark@amc.seoul.kr Jaime De Leon University of Ulsan College of Medicine Estrogen-related receptor...
BioCentury | Aug 11, 2016
Distillery Therapeutics

Therapeutics: Estrogen-related receptor α (ERR-α; ESRRA; NR3B1); epidermal growth factor receptor 2 (HER2; ErbB2; neu)

...and head and neck cancers and Phase II testing for brain and liver cancers. TARGET/MARKER/PATHWAY: Estrogen-related receptor...
BioCentury | Apr 21, 2016
Distillery Therapeutics

Therapeutics: Estrogen-related receptor γ (ESRRG; ERRγ)

...encoding GFP. Next steps include testing the cells in non-human primate models of diabetes. TARGET/MARKER/PATHWAY: Estrogen-related receptor...
BioCentury | Apr 7, 2016
Distillery Therapeutics

Therapeutics: Estrogen-related receptor α (ERR-α; ESRRA; NR3B1); phosphoinositide 3-kinase (PI3K); mammalian target of rapamycin (mTOR; FRAP; RAFT1)

...II testing to treat solid tumors and Phase I testing to treat breast cancer. TARGET/MARKER/PATHWAY: Estrogen-related receptor...
BioCentury | May 21, 2012
Company News

Casigen Pharma, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences deal

...worldwide license to small molecules for diabetes and other metabolic disorders. The preclinical products target estrogen-related receptor...
BioCentury | May 18, 2012
Company News

Diabetes company Casigen debuts

...Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences (GIBH). The preclinical products target estrogen-related receptor...
BioCentury | Nov 3, 2011
Distillery Therapeutics

Indication: Cancer

...Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer Estrogen-related receptor-a (ERRa; ESRRA; NR3B1...
BioCentury | Nov 3, 2011
Distillery Therapeutics

Indication: Autoimmune disease

...2011; doi:10.1084/jem.20110434 Contact: Thomas Korn, Technical University Munich, Munich, Germany e-mail: korn@lrz.tum.de Cancer Breast cancer Estrogen-related receptor-a...
BioCentury | Oct 6, 2011
Distillery Therapeutics

Indication: Cancer

...Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Ovarian cancer Estrogen-related receptor-a (ESRRA; ERRa; NR3B1...
BioCentury | Mar 17, 2011
Distillery Therapeutics

Indication: Cancer

...week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer Estrogen-related receptor-g...
Items per page:
1 - 10 of 15